Veracyte (VCYT) Misses Q2 EPS by 7c

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.40), $0.07 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $14.68 million versus the consensus estimate of $14.81 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM